供货周期: | 现货 |
品牌: | 康朗生物 |
规格: | 0.1ml/0.2ml |
货号: | KL12575R |
CAS号: |
磷酸化乳腺癌抗雌激素耐药蛋白1抗体Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
p130 represents one of several known substrates for v-Crk encoded p47. p130 Cas (for Crk-associated substrate) exhibits a high level of tyrosine phosphorylation and is tightly associated with v-Crk,磷酸化乳腺癌抗雌激素耐药蛋白1抗体 suggesting a role in v-Crk-mediated cell signaling. The molecular cloning of p130 Cas has shown it to represent a novel SH3 containing signaling molecule with a cluster of multiple putative SH2-binding motifs for v-Crk. By immunoprecipitation analysis, p130 Cas has been shown to be highly phosphorylated at tyrosine residues subsequent to either v-Src p60 or v-Crk-mediated transformation and to form stable complexes with both of 磷酸化乳腺癌抗雌激素耐药蛋白1抗体these transforming proteins. p130 Cas behaves as an extremely potent substrate for protein tyrosine kinases and has been reported to relocate from the cytoplasm to cell membrane upon tyrosine phosphorylation. One proposed model is that the SH2 domain of v-Crk functions to activate c-Src kinase, which in turn phosphorylates p130 Cas.
Also known as:
BCAR1 (phospho Y751); BCAR1(phospho Y751); p-BCAR1(p-Tyr751); Breast cancer anti estrogen resistance 1 protein; BCAR 1; Bcar1; BCAR1_HUMAN; Breast cancer anti estrogen resistance 1; Breast cancer anti-estrogen resistance protein 1; CAS; Cas scaffolding protein family member 1;磷酸化乳腺癌抗雌激素耐药蛋白1抗体 Crk associated substrate; Crk associated substrate p130Cas; CRK-associated substrate; CRKAS; P130CAS.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthesised phosphopeptide derived from human BCAR1 around the phosphorylation site of Tyr751.
●
Predicted Molecular Weight: 93kDa.
Storage:
磷酸化乳腺癌抗雌激素耐药蛋白1抗体Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl145Hu01血管内皮生长因子C(VEGFC)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl145Mu01血管内皮生长因子C(VEGFC)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl145Ra01血管内皮生长因子C(VEGFC)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl144Hu01血管内皮生长因子B(VEGFB)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl144Mu01血管内皮生长因子B(VEGFB)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl144Ra01血管内皮生长因子B(VEGFB)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl143Hu01血管内皮生长因子A(VEGFA)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Mu01血管内皮生长因子A(VEGFA)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Ra01血管内皮生长因子A(VEGFA)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl949Hu01转化生长因子β3(TGFβ3)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
kl949Mu01转化生长因子β3(TGFβ3)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
kl949Ra01转化生长因子β3(TGFβ3)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
kl218Hu01转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
kl218Mu01转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
相关产品
关注
拨打电话
留言咨询